- Lower volatility than the market (beta 0.01)
- High gross margin of 70.0%
- Strong operating margin of 25.9%
Protalix BioTherapeutics Inc stock upgraded from Hold/Accumulate to Buy Candidate after Thursday trading session
(Updated on Jun 11, 2026)
The Protalix BioTherapeutics Inc stock price gained 4.06% on the last trading day (Thursday, 11th Jun 2026), rising from $1.97 to $2.05. During the last trading day the stock fluctuated 5.32% from a day low at $1.97 to a day high of $2.08. The price has fallen in 6 of the last 10 days and is down by -2.38% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 279 thousand more shares were traded than the day before. In total, 603 thousand shares were bought and sold for approximately $1.24 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.55% during the next 3 months and, with a 90% probability hold a price between $1.48 and $2.01 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
PLX Signals & Forecast
Mostly positive signals in the chart today. The Protalix BioTherapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.99 and $2.03. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 7.89%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Protalix BioTherapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Support, Risk & Stop-loss for Protalix BioTherapeutics Inc stock
Protalix BioTherapeutics Inc finds support from accumulated volume at $1.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.105 between high and low, or 5.32%. For the last week, the stock has had daily average volatility of 3.41%.
Our recommended stop-loss: $1.94 (-5.33%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 16 days ago.)
Trading Expectations (PLX) For The Upcoming Trading Day Of Friday 12th
For the upcoming trading day on Friday, 12th we expect Protalix BioTherapeutics Inc to open at $2.03, and during the day (based on 14 day Average True Range), to move between $2.01 and $2.09, which gives a possible trading interval of +/-$0.0818 (+/-4.07%) up or down from last closing price. If Protalix BioTherapeutics Inc takes out the full calculated possible swing range there will be an estimated 4.07% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.98 (3.41%) than the resistance at $2.12 (3.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Protalix BioTherapeutics Inc stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
2.546
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 12, 2026 - $2.03 ( 0.89%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PLX Performance
Trading levels for PLX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.14 | 4.22% |
| R2 | 2.10 | 2.27% |
| R1 | 2.07 | 1.06% |
| Price | 2.05 | |
| S1 | 1.99 | -2.85% |
| S2 | 1.97 | -4.06% |
| S3 | 1.93 | -6.01% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.21 | 7.80% |
| R2 | 2.14 | 4.39% |
| R1 | 2.12 | 3.41% |
| Price | 2.05 | |
| S1 | 1.98 | -3.41% |
| S2 | 1.96 | -4.39% |
| S3 | 1.93 | -5.85% |
FAQ
Click here for our free guide on how to buy Protalix BioTherapeutics Inc Stock.
Buy PLX